G. Humble

Safety of Sculptra®: a review of clinical trial data

P. Engelhard, G. Humble, D. Mest, 2005, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Injectable Poly‐l‐Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open‐Label Study (FACES)

A. LaMarca, M. Gold, M. Conant, 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Safety and Efficacy of Poly‐L‐lactic Acid Injections in Persons with HIV‐Associated Lipoatrophy: The US Experience

G. Humble, D. Mest, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Poly-l-Lactic Acid for the Treatment of HIV-Associated Facial Lipoatrophy

G. Humble, D. Mest, 2012 .

Retreatment with Injectable Poly‐l‐Lactic Acid for HIV‐Associated Facial Lipoatrophy: 24‐Month Extension of the Blue Pacific Study

G. Humble, D. Mest, 2009, Dermatologic Surgery.

Duration of Correction for Human Immunodeficiency Virus-Associated Lipoatrophy After Retreatment with Injectable Poly-l-Lactic Acid

G. Humble, D. Mest, 2009, Aesthetic Plastic Surgery.

Soft tissue augmentation using sculptra.

G. Humble, D. Mest, 2004, Facial plastic surgery : FPS.

Injectable Poly‐l‐Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open‐Label Study (FACES)

A. LaMarca, M. Gold, M. Conant, 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].